Adjuvant potential of aggregate-forming polyglutamine domains

被引:19
作者
Ilyinskii, P. O. [2 ]
Thoidis, G. [2 ]
Sherman, M. Y. [1 ]
Shneider, A. [2 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Cure Lab Inc, Canton, MA 02021 USA
关键词
polyglutamine; CTL; adjuvant; vaccine; aggregation; fusion; antibody; autophagy;
D O I
10.1016/j.vaccine.2008.03.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aggregation may significantly affect the fate of a polypeptide, including its susceptibility to proteasome-dependent or autophagic degradation, its interaction with chaperones, etc. Since all these factors may affect the antigenicity of a polypeptide, we hypothesized that stimulating aggregation of an antigenic protein by its fusion to polyQ domain may enhance its antigenic potential. This hypothesis was tested with the weakly immunogenic model antigen GFP, which was fused to either long polyQ domain that triggers protein aggregation (103Q), or short polyQ domain that does not promote aggregation (25Q). Plasmids encoding control pGFP or soluble 25Q-GFP generated a very weak antibody response, while a significant increase in anti-GFP antibody titer was seen in groups immunized with DNA encoding aggregating 103Q-GFP. Similarly, fusion with 103Q strongly enhanced anti-GFP CTL activity, compared to fusion with 25Q. No apparent toxicity was observed after immunization with polyQ-GFP fusions. These data suggest that fusion of an antigen with expanded polyQ domains could have a significant adjuvant potential. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3223 / 3226
页数:4
相关论文
共 34 条
[1]   Vaccine adjuvants revisited [J].
Aguilar, J. C. ;
Rodriguez, E. G. .
VACCINE, 2007, 25 (19) :3752-3762
[2]   Expanded glutamines and neurodegeneration - A gain of insight [J].
Bates, G .
BIOESSAYS, 1996, 18 (03) :175-178
[3]   A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaquesv [J].
Chen, Lan ;
Ewing, Dan ;
Subramanian, Hernavathy ;
Block, Karla ;
Rayner, Jonathan ;
Alterson, Kimberly D. ;
Sedegah, Martha ;
Hayes, Curtis ;
Porter, Kevin ;
Raviprakash, Kanakatte .
JOURNAL OF VIROLOGY, 2007, 81 (21) :11634-11639
[4]   CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs [J].
Cox, Jennifer H. ;
McMichael, Andrew J. ;
Screaton, Gavin R. ;
Xu, Xiao-Ning .
JOURNAL OF IMMUNOLOGY, 2007, 179 (02) :830-836
[5]   Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses [J].
Cuadros, C ;
Lopez-Hernandez, FJ ;
Dominguez, AL ;
McClelland, M ;
Lustgarten, J .
INFECTION AND IMMUNITY, 2004, 72 (05) :2810-2816
[6]   Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis [J].
Gilbert, Sarah C. ;
Moorthy, Vasee S. ;
Andrews, Laura ;
Pathan, Ansar A. ;
McConkey, Samuel J. ;
Vuola, Jenni M. ;
Keating, Sheila M. ;
Berthoud, Tamara ;
Webster, Daniel ;
McShane, Helen ;
Hill, Adrian V. S. .
VACCINE, 2006, 24 (21) :4554-4561
[7]   Comparison of two cancer vaccines targeting tyrosinase:: Plasmid DNA and recombinant alphavirus replicon particles [J].
Goldberg, SM ;
Bartido, SM ;
Gardner, JP ;
Guevara-Patiño, JA ;
Montgomery, SC ;
Perales, MA ;
Maughan, MF ;
Dempsey, JA ;
Donovan, GP ;
Olson, WC ;
Houghton, AN ;
Wolchok, JD .
CLINICAL CANCER RESEARCH, 2005, 11 (22) :8114-8121
[8]   Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells [J].
Herter, S ;
Osterloh, P ;
Hilf, N ;
Rechtsteiner, G ;
Höhfeld, J ;
Rammensee, HG ;
Schild, H .
JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :891-898
[9]   Autophagy and human disease [J].
Huang, Ju ;
Klionsky, Daniel J. .
CELL CYCLE, 2007, 6 (15) :1837-1849
[10]   Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production [J].
Iyer, S ;
HogenEsch, H ;
Hem, SL .
VACCINE, 2003, 21 (11-12) :1219-1223